Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cerebral haemorrhage 7 days after successful surgery resulting in death of date 29Apr2021 No complaints after vaccination.; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority NL-LRB-00536980, received from Regulatory Authority. A 74-year-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 13Apr2021 (Batch/Lot Number: EW9127) as single dose for covid-19 immunisation; clopidogrel (manufacturer unknown, 75 mg), via an unspecified route of administration from 06Apr2021 (Batch/Lot Number: Unknown) to an unspecified date, at unspecified dose daily in connection with carotid artery narrowing/surgery in 21Apr2021. The patient''s medical history was not reported. Concomitant medications included non specified blood pressure medication, and non specified cholesterol lowering agent (In connection with surgery under anesthesia, blood pressure reducer/blood thinner/cholestorol reducer were prescribed). The patient experienced cerebral haemorrhage on 28Apr2021, 7 days after successful surgery resulting in death of date 29Apr2021, no complaints after vaccination. The outcome of cerebral haemorrhage was fatal. The action taken in response to the event for clopidogrel was not applicable. It was unknown if an autopsy was performed. Patient had no previous COVID-19 infection. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Cerebral haemorrhage
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166